Top compounds associated with response to PRSS1


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.068 0.03
mRNA temsirolimus CTRPv2 pan-cancer AAC -0.091 0.05
mRNA thalidomide CTRPv2 pan-cancer AAC 0.019 0.7
mRNA thapsigargin gCSI pan-cancer AAC -0.03 0.6
mRNA tigecycline CTRPv2 pan-cancer AAC 0.017 0.7
mRNA tipifarnib CTRPv2 pan-cancer AAC -0.03 0.3
mRNA tivantinib CTRPv2 pan-cancer AAC -0.0037 0.9
mRNA tivozanib CTRPv2 pan-cancer AAC -0.024 0.5
mRNA tosedostat CTRPv2 pan-cancer AAC 0.034 0.3
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0002
Download CSV